ABCB4 Gene (ATP Binding Cassette Subfamily B Member 4)

ABCB4: A key transporter in biliary phospholipid secretion and its role in cholestatic liver diseases and drug-induced liver injury.

Gene Information Card

Symbol ABCB4
Full Name ATP Binding Cassette Subfamily B Member 4
Gene Type Protein coding
Chromosomal Location 7q21.12
NCBI Gene ID 5244 ncbi.nlm.nih.gov/gene/5244
Ensembl ID ENSG00000005471
UniProt ID P21439
OMIM ID 171060
HGNC ID 45
Aliases MDR3, MDR2, PFIC3, ABC21, GBD1

Description

The ABCB4 gene encodes the multidrug resistance protein 3 (MDR3), a member of the ATP-binding cassette (ABC) transporter superfamily. MDR3 is primarily expressed in the canalicular membrane of hepatocytes and functions as a floppase that translocates phosphatidylcholine from the inner to the outer leaflet of the canalicular membrane, facilitating its secretion into bile. This phospholipid secretion is essential for micelle formation and protection of the biliary epithelium from detergent bile salts. Mutations in ABCB4 cause progressive familial intrahepatic cholestasis type 3 (PFIC3), low phospholipid-associated cholelithiasis (LPAC), and intrahepatic cholestasis of pregnancy (ICP).

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Progressive Familial Intrahepatic Cholestasis 3 (PFIC3) Loss-of-function mutations impair phosphatidylcholine secretion, leading to toxic bile salt accumulation and progressive liver damage. ClinVar, OMIM #171060
Low Phospholipid-Associated Cholelithiasis (LPAC) Partial deficiency of MDR3 reduces biliary phospholipid levels, promoting cholesterol gallstone formation and intrahepatic sludge. OMIM #600803, PubMed
Intrahepatic Cholestasis of Pregnancy (ICP) Heterozygous ABCB4 variants reduce transporter activity, exacerbated by hormonal changes, causing pruritus and elevated bile acids. ClinVar, OMIM #147480
Drug-Induced Liver Injury (DILI) ABCB4 polymorphisms may increase susceptibility to cholestatic DILI by impairing biliary phospholipid secretion. PubMed, ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.8 High
Gallbladder 8.5 Medium
Small Intestine 3.2 Low
Kidney 1.1 Not detected
Lung 0.5 Not detected
Cell Line Expression
Cell Line nTPM Notes
HepG2 15.2 Hepatocellular carcinoma cell line; high expression
Huh-7 11.4 Hepatoma cell line; moderate expression
Caco-2 2.1 Colorectal adenocarcinoma; low expression
HEK293 0.3 Embryonic kidney; not detected
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.504C>T (p.Arg168Cys) Missense Common in PFIC3 Loss of function; reduced phospholipid transport
c.959C>T (p.Thr320Ile) Missense Associated with LPAC Partial loss of function; decreased floppase activity
c.1331T>C (p.Val444Ala) Missense Polymorphism (rs2109505) Moderate effect; risk factor for ICP and DILI
c.1769G>A (p.Arg590Gln) Missense Rare in PFIC3 Loss of function; impaired ATP binding
Mutation functional classification

Loss of Function (LOF)

Most PFIC3-associated mutations (e.g., p.Arg168Cys, p.Arg590Gln) cause complete or near-complete loss of phosphatidylcholine floppase activity, leading to severe cholestasis.

Gain of Function (GOF)

No gain-of-function mutations have been reported for ABCB4.

Dominant Negative (DN)

Some heterozygous missense variants (e.g., p.Thr320Ile) may exert a dominant-negative effect by disrupting dimerization or ATPase activity, contributing to LPAC or ICP.

Gene Ontology (GO)

• GO:0005524~ATP binding • GO:0017127~cholesterol floppase activity
• GO:0015431~phosphatidylcholine floppase activity • GO:0015908~phosphatidylcholine transport
• GO:0016324~apical plasma membrane • GO:0042493~response to drug
• GO:0032869~cellular response to bile acid

Pathways

Bile secretion (KEGG hsa04976)
ABC transporters (KEGG hsa02010)
Phospholipid homeostasis (Reactome R-HSA-1483206)

Protein Summary

MDR3 (ABCB4) is a 1279-amino acid transmembrane glycoprotein with two nucleotide-binding domains (NBDs) and two transmembrane domains (TMDs). It functions as a homodimer or heterodimer with other ABC transporters. The protein is localized to the canalicular membrane of hepatocytes and uses ATP hydrolysis to translocate phosphatidylcholine into bile. This activity is critical for biliary lipid secretion and protection against bile salt toxicity. Structural mutations in the NBDs or TMDs disrupt ATPase activity or substrate recognition, leading to cholestatic liver diseases.

Related Products

Product name Cat.No. Species Gene ID
ABCB4 Knockout HEK293 Cell Line EDJ-KQ3577 Human 5244 Details Get a Quote
ABCB4 Knockout HeLa Cell Line EDJ-KQ54132 Human 5244 Details Get a Quote
ABCB4 Knockout A-549 Cell Line EDJ-KQ62622 Human 5244 Details Get a Quote
ABCB4 Knockout HCT 116 Cell Line EDJ-KQ71093 Human 5244 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: